Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

A Patient With CD20-positive T-cell Lymphoma Concurrently Exhibiting B-cell Neoplasm-related Genetic Abnormalities Shows Clonal Escape Post CD20-targeting Treatment

  • Jiyeon Kim (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Miyoung Kim (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Young-Uk Cho (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Sang-Hyun Hwang (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seongsoo Jang (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Eul-Ju Seo (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Dok Hyun Yoon (Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Heounjeong Go (Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chan-Jeoung Park (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2022.05.31
  • Accepted : 2022.09.29
  • Published : 2023.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Yao X, Teruya-Feldstein J, Raffeld M, Sorbara L, Jaffe, ES. Peripheral Tcell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall. Mod Pathol 2001;14:105-10. https://doi.org/10.1038/modpathol.3880265
  2. Mangogna A, Cox MC, Ruco L, Lopez G, Belmonte B, Di Napoli A. Rituximab plus chemotherapy provides no clinical benefit in a peripheral Tcell lymphoma not otherwise specified with aberrant Expression of CD20 and CD79a: a case report and review of the literature. Diagnostics (Basel) 202026;10:341. https://doi.org/10.3390/diagnostics10060341
  3. Imai M, Jiang JG, Wu Z, Dabbas B, Ni H. CD20-positive T-cell lymphoma involving bone marrow: report of four cases. J Hematopathol 2013; 6:201-5. https://doi.org/10.1007/s12308-013-0177-9
  4. Manso R, Rodríguez-Pinilla SM, González-Rincón J, Gómez S, Monsalvo S, Llamas P, et al. Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas. Haematologica 2015;100:e25-7. https://doi.org/10.3324/haematol.2014.113696
  5. The Atlas of Genetics and Cytogenetics in Oncology and Haematology. https://atlasgeneticsoncology.org/ (Updated on Aug 2022).
  6. Magro CM, Seilstad KH, Porcu P, Morrisson CD. Primary CD20+CD10+ CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement. Am J Clin Pathol 2006;126:14-22. https://doi.org/10.1309/HPYGFLNXKFBHDQEV
  7. Zhang Y, Wang K, Tan Q, Yang K, Wu D, Xu Y, et al. Primary breast CD20- positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review. Diagn Pathol 2021;16:103. https://doi.org/10.1186/s13000-021-01166-4
  8. Lazzi S, Bellan C, Onnis A, De Falco G, Sayed S, Kostopoulos I, et al. Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis. Hum Pathol 2009;40: 1252-61. https://doi.org/10.1016/j.humpath.2009.01.007
  9. van Dongen JJ, Langerak AW, Brüggemann M, Evans PAS, Lavender FL, Delabesse E, el al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317. https://doi.org/10.1038/sj.leu.2403202
  10. Shao Y, Bai C, Sun J, Goa X. T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report. Medicine (Baltimore) 2018;97:e0199. https://doi.org/10.1097/MD.0000000000010199